Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Mar 20 | BCRX | Biocryst Pharmaceuticals… | MEXER◆ | 49,933 | — | — | — | Open the original filing on SEC.gov |
| Mar 20 | BCRX | Biocryst Pharmaceuticals… | SSELL | 49,933 | $10.11 | $504.8K | -43.3% | Open the original filing on SEC.gov |
| Mar 20 | BCRX | Biocryst Pharmaceuticals… | MEXER | 49,933 | $6.30 | $314.6K | +76.4% | Open the original filing on SEC.gov |
| Aug 13, 2025 | BCRX | Biocryst Pharmaceuticals… | MEXER◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 13, 2025 | BCRX | Biocryst Pharmaceuticals… | MEXER◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 13, 2025 | BCRX | Biocryst Pharmaceuticals… | SSELL | 70,000 | $8.51 | $595.9K | -51.7% | Open the original filing on SEC.gov |
| Aug 13, 2025 | BCRX | Biocryst Pharmaceuticals… | MEXER | 40,000 | $5.41 | $216.4K | +41.9% | Open the original filing on SEC.gov |
| Aug 13, 2025 | BCRX | Biocryst Pharmaceuticals… | MEXER | 30,000 | $2.91 | $87.3K | +45.9% | Open the original filing on SEC.gov |
| Jun 12, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT◆ | 27,181 | — | — | — | Open the original filing on SEC.gov |
| Jun 12, 2025 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 12,500 | — | — | +23.6% | Open the original filing on SEC.gov |